Physician profile
Adeeb Aghdassi
NPI 1346509700
$20,108.76
in general payments reported to CMS, 2019-2025
38 companies · $2,997 in 2025
The $2,997 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $29.36 · 2021: $9,972 · 2022: $1,426 · 2023: $3,970 · 2024: $1,354 · 2025: $2,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,791 · Travel and Lodging: $3,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,791.31 |
| Travel and Lodging | $3,530.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,232.27 | 2019-2025 | Optis, Esprit, Supera |
| Medtronic, INC. | $3,624.14 | 2021-2025 | Linq II, Spiderfx, Azure Xt Dr Mri Surescan |
| Penumbra, INC. | $1,021.17 | 2023 | Indigo System |
| Shockwave Medical, INC | $356.67 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $352.38 | 2024-2025 | Ozempic, Wegovy |
| Heartflow, INC. | $227.60 | 2024 | |
| Novartis Pharmaceuticals Corporation | $215.58 | 2020-2025 | |
| Scpharmaceuticals INC. | $207.71 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $201.01 | 2020-2025 | Camzyos |
| Abiomed | $187.98 | 2024-2025 | Impella |
| Bridgebio Pharma, INC. | $168.72 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.62 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $136.55 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $135.44 | 2019-2025 | Varithena Administration Pack, Watchman Access System, Avvigo Guidance System |
| Philips North America LLC | $127.82 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $126.64 | 2024 | Carto 3 |
| Ionis Pharmaceuticals, INC. | $122.03 | 2025 | Tryngolza |
| Amgen INC. | $121.03 | 2023-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $118.98 | 2025 | |
| Merck Sharp & Dohme LLC | $115.69 | 2024-2025 | Verquvo, Capvaxive |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $99.00 | 2021 | |
| Angiodynamics, INC. | $75.38 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $60.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.64 | 2019-2024 | Xarelto |
| Pfizer INC. | $43.89 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.34 | 2024-2025 | Jardiance |
| Silk Road Medical, INC. | $38.15 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Terumo Medical Corporation | $30.81 | 2024 | Metacross Otw |
| Cvrx, INC. | $29.85 | 2025 | Barostim Neo System |
| Recor Medical INC | $28.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Sanofi-Aventis U.S. LLC | $27.69 | 2024 | |
| W. L. Gore & Associates, INC. | $25.73 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cook Medical LLC | $25.66 | 2024 | Zilver Vena, Icast Covered Stent System, 6mmx22mmx120cm |
| Coopersurgical, INC. | $23.84 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $22.95 | 2025 | Opsumit |
| Chiesi USA, INC. | $16.90 | 2025 | Kengreal |
| Lexicon Pharmaceuticals, INC. | $13.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeeb Aghdassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.